Cita APA (7a ed.)

Liu, J., Xie, Y., Guo, J., Li, X., Wang, J., Jiang, H., . . . Liu, Z. (2021). Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nature Portfolio.

Cita Chicago Style (17a ed.)

Liu, Jing, et al. Targeting NSD2-mediated SRC-3 Liquid–liquid Phase Separation Sensitizes Bortezomib Treatment in Multiple Myeloma. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Liu, Jing, et al. Targeting NSD2-mediated SRC-3 Liquid–liquid Phase Separation Sensitizes Bortezomib Treatment in Multiple Myeloma. Nature Portfolio, 2021.